8-K 1 form8-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 3, 2021 (October 29, 2021)

 

Vision Sensing Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

Delaware   001- 40983   87-2323481

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

Suite 500, 78 SW 7th Street

Miami, Florida 33130

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (786) 633-2520

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Units, each consisting of one share of Class A common stock, par value $0.0001 per share, and three-quarters of one Redeemable Warrant   VSACU   The Nasdaq Stock Market LLC
Shares of Class A common stock, par value $0.0001 per share, included as part of the Units   VSAC   The Nasdaq Stock Market LLC
Redeemable Warrants, each exercisable for one share of Class A common stock for $11.50 per share, included as part of the Units   VSACW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On November 3, 2021, Vision Sensing Acquisition Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 10,120,000 units (the “Units”), including 1,320,000 Units issued pursuant to the full exercise by the underwriters of their over-allotment option. Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), and three-quarters of one redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $101,200,000.

 

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statement on Form S-1 (File No. 333-259766) related to the IPO, originally filed with the U.S. Securities and Exchange Commission (the “Commission”) on September 24, 2021 (as amended, the “Registration Statement”):

 

  An Underwriting Agreement, dated October 29, 2021, by and between the Company and EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.
     
  A Warrant Agreement, dated November 1, 2021, by and between the Company and Continental Stock Transfer & Trust Company (“CST”), as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.
     
  A Letter Agreement, dated November 1, 2021, by and among the Company, its officers, its directors and the Company’s sponsor, Vision Sensing LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.
     
  An Investment Management Trust Agreement, dated November 1, 2021, by and between the Company and CST, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.
     
  A Registration Rights Agreement, dated November 1, 2021, by and among the Company, the Sponsor, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.
     
  A Placement Unit Purchase Agreement, dated November 1, 2021 (the “Placement Unit Purchase Agreement”), by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.
     
  Indemnity Agreements, dated November 1, 2021, by and between the Company and each of the directors and officers of the Company, a form of which is attached as Exhibit 10.5 hereto and incorporated by reference.
     
  An Administrative Support Agreement, dated November 1, 2021, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.

 

 

 

 

Item 3.02. Unregistered Sales of Equity Securities.

 

Simultaneously with the closing of the IPO, pursuant to the Placement Unit Purchase Agreement, the Company completed the private sale of an aggregate of 427,700 units (the “Placement Units”), including 46,200 Placement Units issued pursuant to the underwriters’ exercise of the over-allotment option in full, to the Sponsor at a purchase price of $10.00 per Placement Unit, generating gross proceeds to the Company of $4,727,000. The Placement Units are identical to the Units sold in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 29, 2021 and in connection with the IPO, Joseph Mitchell Magen, William Welser IV and Garry Richard Stein (the “Directors”) were appointed to the board of directors of the Company (the “Board”). The Directors are independent directors.

 

Effective October 29, 2021, Messrs. Magen, Welser and Stein were appointed to the Board’s audit committee, with Mr. Stein serving as chair. Effective October 29, 2021, Messrs. Magen, Welser and Stein were appointed to the Board’s compensation committee, with Mr. Magen serving as chair.

 

Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, Class I, consists of George Peter Sobek and will expire at the Company’s first annual meeting of stockholders; the term of office of the second class of directors, Class II, consists of Hang Kon Louis Ma and will expire at the Company’s second annual meeting of stockholders; and the term of office of the third class of directors, Class III, consists of Joseph Mitchell Magen, William Welser IV and Garry Richard Stein and will expire at the Company’s third annual meeting of stockholders.

 

On November 1, 2021, in connection with their appointments to the Board, each Director entered into the Letter Agreement as well as the Indemnity Agreement with the Company.

 

Other than the foregoing, none of the Directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.

 

The foregoing descriptions of the Letter Agreement and the form of Indemnity Agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and form of Indemnity Agreement, copies of which are attached as Exhibit 10.1 hereto and Exhibit 10.5, respectively, and are incorporated herein by reference.

 

Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

 

On October 20, 2021 and in connection with the IPO, the stockholders of the Company approved and adopted the Company’s Amended and Restated Certificate of Incorporation (the “A&R COI”). The terms of the A&R COI are set forth in the Registration Statement and are incorporated herein by reference. A copy of the A&R COI is attached as Exhibit 3.1 hereto and incorporated herein by reference.

 

 

 

 

Item 8.01. Other Events.

 

A total of $102,718,000, comprised of the proceeds from the IPO after offering expenses and the proceeds of the sale of the Placement Units, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes (less up to $100,000 interest to pay dissolution expenses), the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (a) to modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business combination within 12 months (or up to 18 months if the Company extends the time to complete a business combination as described in the Registration Statement) from the closing of the IPO or (b) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity and (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 12 months (or up to 18 months if the Company extends the time to complete a business combination as described in the Registration Statement) from the closing of the IPO, subject to applicable law.

 

On October 29, 2021, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

On November 3, 2021, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

The following exhibits are being filed herewith:

 

Exhibit No.   Description
     
1.1   Underwriting Agreement, dated October 29, 2021 by and between the Company and EF Hutton, division of Benchmark Investments, LLC, as representative of the several underwriters.
     
3.1   Amended and Restated Certificate of Incorporation.
     
4.1   Warrant Agreement, dated November 1, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
     
10.1   Letter Agreement, dated November 1, 2021, by and among the Company, its officers, its directors and the Sponsor.
     
10.2   Investment Management Trust Agreement, dated November 1, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.
     
10.3   Registration Rights Agreement, dated November 1, 2021, by and between the Company and the Sponsor.
     
10.4   Placement Unit Purchase Agreement, dated November 1, 2021, by and between the Company and the Sponsor.
     
10.5   Form of Indemnity Agreement, dated November 1, 2021, by and among the Company and each of the directors and officers of the Company.
     
10.6   Administrative Support Agreement, dated November 1, 2021, by and between the Company and the Sponsor.
     
99.1   Press Release, dated October 29, 2021.
     
99.2   Press Release, dated November 3, 2021.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

  Vision Sensing Acquisition Corp.
   
  By: /s/ George Peter Sobek
  Name: George Peter Sobek
  Title: Chairman and Chief Executive Officer

 

Dated: November 3, 2021